Are you Dr. Han?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 8 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
17100 Euclid St
Fountain Valley, CA 92708Phone+1 714-949-1211Fax+1 714-647-1245
Summary
- Dr. Dong Han, MD is a board certified anesthesiologist in Fountain Valley, California. He is currently licensed to practice medicine in California.
Education & Training
Mount Sinai Beth Israel HospitalResidency, Anesthesiology, 1969 - 1970
University of MichiganResidency, Anesthesiology, 1967 - 1969
Detroit Medical Center/Wayne State University (Sinai-Grace)Internship, Transitional Year, 1966 - 1967
Seoul National University College of MedicineClass of 1966
Certifications & Licensure
CA State Medical License 1973 - 2025
American Board of Anesthesiology Anesthesiology
Clinical Trials
- Clinical Course of Korean Crohn's Disease Cohort Start of enrollment: 2012 Dec 01
Publications & Presentations
PubMed
- 12 citationsRole of innate lymphoid cells in chronic colitis during anti-IL-17A therapyChan Hyuk Park, A-reum Lee, Sang Bong Ahn, Chang Soo Eun, Dong Soo Han
Scientific Reports. 2020-01-15 - 17 citationsNetwork construction of gastric microbiome and organization of microbial modules associated with gastric carcinogenesis.Chan Hyuk Park, Jae Gon Lee, A-reum Lee, Chang Soo Eun, Dong Soo Han
Scientific Reports. 2019-08-27 - 4 citationsAntiallodynic Effects of Intrathecal Areca Nut for Spinal Nerve-Ligated and Chemotherapy-Induced Neuropathic Pain in Rats.Hyung Gon Lee, Ji A Song, Dong Soo Han, Kyeong Wan Woo, Myung Ha Yoon
Pharmacology. 2018-01-01
Press Mentions
- Amiodarone Inhibits Arrhythmias in Hypertensive Rats by Improving Myocardial Biomechanical PropertiesDecember 10th, 2020
Cardio-Oncology Topics from AHA 2019April 23rd, 2020
Cellular Biomedicine Group (CBMG) Acquiring Chinese PLA General Hospital's CAR-T (CD19/CD20/CD30/EGFR) Immuno-Oncology Technology and Clinical DataFebruary 9th, 2015
